The Director of The University of Queensland’s Institute for Molecular Bioscience (IMB) will help steer a national initiative striving to double survival rates for people with brain cancer over the next decade.
An international team of researchers has found a drug previously approved to treat breast cancer could also be used to shrink medulloblastoma, a common form of childhood brain tumour.
IMB researchers have found a promising small molecule treatment that blocked cancer spread and improved survival rates in mice in a pre-clinical study of breast cancer.
A $2.3M grant from Australian Cancer Research Foundation (ACRF) is being awarded to UQ IMB today to establish the new ACRF Cancer Ultrastructure and Function Facility (CUFF). The nation-leading facility will provide cutting-edge imaging capabilities for tracking and visualising cancer.
IMB's Professor Kirill Alexandrov has been awarded a 2015 National Breast Cancer Foundation Innovator Grant to investigate the potential of a new diagnostic test for advanced breast cancer.
Scientists from Australia and the UK have completed the most comprehensive analysis yet of pancreatic cancer, in a study that could improve future treatments.
University of Queensland researchers have discovered a way of predicting cancer-free survival in breast cancer patients and identified a new treatment target.
University of Queensland scientists have succeeded in identifying the major underlying mutations in pancreatic and ovarian cancers, two of Australia’s most ruthless cancers.
